FrancophonIA/ELRC3.0 huggingface dataset:
English: Red and yellow ferric oxides Carnauba wax
Latvian: Dzelzs oksīdi, sarkanais un dzeltenais Karnauba vasks
English: CoAprovel 300 mg/25 mg may be administered in patients insufficiently controlled by CoAprovel 300 mg/12.5 mg.
Latvian: CoAprovel 300 mg/25 mg var lietot pacientiem, kam asinsspiedienu nevar pietiekami kontrolēt ar CoAprovel 300 mg/12,5 mg.
English: Each tablet contains 26.65 mg of lactose (as lactose monohydrate).
Latvian: Katra tablete satur 26,65 mg laktozes (laktozes monohidrāta veidā).
English: Irbesartan exhibits linear and dose proportional pharmacokinetics over the dose range of 10 to 600 mg. A less than proportional increase in oral absorption at doses beyond 600 mg was observed; the mechanism for this is unknown.
Latvian: Lietojot par 600 mg lielāku devu, novēro mazāk nekā proporcionālu perorālās uzsūkšanās palielināšanos; šīs atradnes mehānisms nav zināms.
English: jaundice hepatitis, abnormal liver function
Latvian: dzelte hepatīts, patoloģiska aknu darbība
English: The addition of 12.5 mg hydrochlorothiazide to 300 mg irbesartan once daily in patients not adequately controlled on 300 mg irbesartan alone resulted in further placebo-corrected diastolic blood pressure reductions at trough (24 hours post-dosing) of 6.1 mm Hg.
Latvian: Pacientiem, kuru stāvokli neizdodas pietiekami uzlabot tikai ar 300 mg irbesartāna, 12,5 mg hidrohlortiazīda devas pievienošana 300 mg irbesartānam reizi dienā izraisīja turpmāku, ar placebo salīdzinātu diastoliskā asinsspiediena pazemināšanos par 6,1 mmHg pie zāļu minimālās koncentrācijas asinīs (24 stundas pēc lietošanas).
English: CoAprovel 150 mg/12.5 mg may be administered in patients whose blood pressure is not adequately controlled with hydrochlorothiazide or irbesartan 150 mg alone;
Latvian: CoAprovel 150 mg/12,5 mg var lietot pacientiem, kam asinsspiedienu nevar pietiekami kontrolēt ar hidrohlortiazīda vai 150 mg irbesartāna monoterapiju;
English: CoAprovel is unlikely to affect your ability to drive or use machines.
Latvian: Transportlīdzekļu vadīšana un mehānismu apkalpošana Maz ticams, ka CoAprovel varētu ietekmēt spēju vadīt transportlīdzekļus vai apkalpot mehānismus.
English: nausea/vomiting
Latvian: slikta dūša/vemšana
English: Once daily dosing with 150 mg irbesartan and 12.5 mg hydrochlorothiazide gave systolic/diastolic mean placebo-adjusted blood pressure reductions at trough (24 hours post-dosing) of 12.9/6.9 mm Hg in patients with mild-to-moderate hypertension.
Latvian: Pacientiem ar vieglas līdz vidēji smagas pakāpes hipertensiju 150 mg irbesartāna un 12,5 mg hidrohlortiazīda lietošana reizi dienā izraisīja vidēju, ar placebo kontrolētu sistoliskā/diastoliskā asinsspiediena pazemināšanos par 12,9/6,9 mmHg pie zāļu minimālās koncentrācijas asinīs (24 stundas pēc lietošanas).
English: headache
Latvian: galvassāpes
English: Each film-coated tablet contains 89.5 mg of lactose (as lactose monohydrate).
Latvian: Katra apvalkotā tablete satur 89,5 mg laktozes (laktozes monohidrāta veidā).
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 300 mg/25 mg film-coated tablets.
Latvian: ZĀĻU NOSAUKUMS CoAprovel 300 mg/25 mg apvalkotās tabletes.
English: No dosage adjustment is necessary in patients with renal impairment whose creatinine clearance is ≥ 30 ml/min.
Latvian: Pacientiem ar nieru darbības traucējumiem, kam kreatinīna klīrenss ir ≥ 30 ml/min, deva nav jāpielāgo.
English: You may need to have blood checks if you take: potassium supplements salt substitutes containing potassium potassium sparing medicines or other diuretics (water tablets) some laxatives medicines for the treatment of gout therapeutic vitamin D supplements medicines to control heart rhythm medicines for diabetes (oral agents or insulins) carbamazepine (a medicine for the treatment of epilepsy).
Latvian: Iespējams, ka Jums būs jāveic asins analīzes, ja Jūs lietojat: kālija uztura bagātinātājus, kāliju saturošus sāls aizstājējus, kāliju saudzējošas zāles vai citus diurētiķus (urīndzenošus līdzekļus), dažus caurejas līdzekļus,
English: Because no information is available regarding the use of CoAprovel during breast-feeding, CoAprovel is not recommended and alternative treatments with better established safety profiles during breastfeeding are preferable, especially while nursing a newborn or preterm infant.
Latvian: Pacientēm ir jāordinē alternatīva terapija ar labāku vispāratzītu drošuma raksturojumu zīdīšanas laikā, īpaši, barojot ar krūti jaundzimušo vai priekšlaicīgi dzimušu zīdaini.
English: Each tablet contains 65.8 mg of lactose (as lactose monohydrate).
Latvian: Katra tablete satur 65,8 mg laktozes (laktozes monohidrāta veidā).
English: Each film-coated tablet of CoAprovel 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
Latvian: Katra CoAprovel 300 mg/25 mg apvalkotā tablete satur 300 mg irbesartāna un 25 mg hidrohlortiazīda.
English: Each film-coated tablet contains 53.3 mg of lactose (as lactose monohydrate).
Latvian: Katra apvalkotā tablete satur 53,3 mg laktozes (laktozes monohidrāta veidā).
English: cases of hypersensitivity reactions such as angioedema, rash, urticaria
Latvian: paaugstinātas jutības reakciju gadījumi kā angioneirotiskā tūska, izsitumi, nātrene
English: Cartons of 56 x 1 tablets in PVC/PVDC/Aluminium perforated unit dose blisters.
Latvian: Kastīte ar 56 x 1 tableti PVH/PVDH/alumīnija perforēti blisteri ar vienu devu kontūrligzdā.
English: Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or to other sulfonamide-derived substances (hydrochlorothiazide is a sulfonamide-derived substance) Second and third trimesters of pregnancy (see sections 4.4 and 4.6) Severe renal impairment (creatinine clearance < 30 ml/min) Refractory hypokalaemia, hypercalcaemia
Latvian: Paaugstināta jutība pret aktīvām vielām, jebkuru no 6.1. apakšpunktā uzskaitītajām palīgvielām vai citiem sulfonamīdu atvasinājumiem (hidrohlortiazīds ir sulfonamīda atvasinājums).
English: Sun
Latvian: Sv
English: Adequate monitoring of serum potassium in patients at risk is recommended.
Latvian: Pacientiem ar risku ieteicams regulāri kontrolēt kālija līmeni serumā.
English: pain in joints and muscles, liver function abnormal and impaired kidney function, increased level of potassium in your blood and allergic reactions such as rash, hives, swelling of the face, lips, mouth, tongue or throat.
Latvian: palielināts kālija līmenis asinīs un tādas alerģiskas reakcijas kā izsitumi, nātrene, sejas, lūpu, mutes, mēles vai rīkles pietūkums.
English: CoAprovel 300 mg/12.5 mg may be administered in patients insufficiently controlled by irbesartan 300 mg or by CoAprovel 150 mg/12.5 mg.
Latvian: CoAprovel 300 mg/12,5 mg var lietot pacientiem, kam asinsspiedienu nevar pietiekami kontrolēt ar 300 mg irbesartāna vai CoAprovel 150 mg/12,5 mg;
English: Chinoin Private Co. Ltd. Lévai u.5.
Latvian: Lévai u.5.
English: Undesirable effects where the frequency is not known are: headache, ringing in the ears, cough, taste disturbance, indigestion,
Latvian: Blakusparādības, kuru biežums nav zināms, ir: galvassāpes, zvanīšana ausīs, klepus, garšas sajūtas traucējumi, gremošanas traucējumi, sāpes locītavās un muskuļos, aknu darbības traucējumi un pavājināta nieru darbība,
English: Corticosteroids, ACTH: electrolyte depletion, particularly hypokalaemia, may be increased; Digitalis glycosides: thiazide induced hypokalaemia or hypomagnaesemia favour the onset of digitalis-induced cardiac arrhythmias (see section 4.4);
Latvian: Sirds glikozīdi: tiazīdu izraisīta hipokalēmija vai hipomagniēmija veicina sirds glikozīdu izraisītas sirds aritmijas (skatīt 4.4. apakšpunktu).
English: No dosage adjustment of CoAprovel is necessary in patients with mild to moderate hepatic impairment (see section 4.3).
Latvian: Pacientiem ar viegli vai vidēji smagu pavājinātu aknu darbību CoAprovel deva nav jāpielāgo (skatīt 4.3. apakšpunktu).
English: Pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Latvian: Rozā, abpusēji izliekta, ovālas formas tablete ar sirdsveida iespiedumu vienā pusē un numuru 2788 otrā pusē.
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 150 mg/12.5 mg tablets.
Latvian: ZĀĻU NOSAUKUMS CoAprovel 150 mg/12,5 mg tabletes.
English: tinnitus
Latvian: reibonis
English: Thu
Latvian: T
English: chest pain
Latvian: Barošana ar krūti
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 300 mg/12.5 mg tablets.
Latvian: ZĀĻU NOSAUKUMS CoAprovel 300 mg/12,5 mg tabletes.
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER sanofi-aventis groupe EXPIRY DATE
Latvian: ZĀĻU NOSAUKUMS CoAprovel 150 mg/12,5 mg tabletes Irbesartanum/hydrochlorothiazidum REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKA NOSAUKUMS sanofi-aventis groupe DERĪGUMA TERMIŅŠ
English: Non-steroidal anti-inflammatory drugs: the administration of a non-steroidal anti-inflammatory drug may reduce the diuretic, natriuretic and antihypertensive effects of thiazide diuretics in some patients; Pressor amines (e.g. noradrenaline): the effect of pressor amines may be decreased, but not sufficiently to preclude their use;
Latvian: Asinsspiedienu paaugstinoši amīni (piemēram, noradrenalīns): asinsspiedienu paaugstinošu amīnu ietekme var mazināties, taču ne tik lielā mērā, lai izslēgtu to lietošanu.
English: 5.1 Pharmacodynamic properties
Latvian: 5 FARMAKOLOĢISKĀS ĪPAŠĪBAS
English: Medicinal products affected by serum potassium disturbances: periodic monitoring of serum potassium is recommended when CoAprovel is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics).
Latvian: Zāles, ko ietekmē kālija līmeņa pārmaiņas serumā: lietojot CoAprovel kopā ar zālēm, ko ietekmē kālija līmeņa pārmaiņas serumā (piemēram, sirds glikozīdiem, antiaritmiskiem līdzekļiem), ieteicams periodiski kontrolēt kālija līmeni serumā.
English: Ear and labyrinth disorders:
Latvian: Ausu un labirinta bojājumi
English: Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate
Latvian: Laktozes monohidrāts Mikrokristāliska celuloze Kroskarmelozes nātrija sāls Preželatinizēta ciete Silīcija dioksīds
English: EU/1/98/086/008 - 14 tablets EU/1/98/086/004 - 28 tablets EU/1/98/086/005 - 56 tablets EU/1/98/086/010 - 56 x 1 tablets EU/1/98/086/006 - 98 tablets
Latvian: EU/1/98/086/008 - 14 tabletes EU/1/98/086/004 - 28 tabletes EU/1/98/086/005 - 56 tabletes EU/1/98/086/010 - 56 x 1 tabletes EU/1/98/086/006 - 98 tabletes
English: CoAprovel 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Latvian: CoAprovel 150 mg/12,5 mg tabletes ir iepakotas blisteru plāksnītēs pa 14, 28, 56 vai 98 tabletēm.
English: Hydrochlorothiazide
Latvian: Hidrohlortiazīds
English: Cartons of 56 tablets in PVC/PVDC/Aluminium blisters.
Latvian: Kastīte ar 56 tabletēm PVH/PVDH/alumīnija blisterī.
English: Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 25 mg
Latvian: Katra tablete satur 300 mg irbesartāna un 25 mg hidrohlortiazīda
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER sanofi-aventis groupe EXPIRY DATE
Latvian: ZĀĻU NOSAUKUMS CoAprovel 300 mg/12,5 mg tabletes Irbesartanum/hydrochlorothiazidum REĢISTRĀCIJAS APLIECĪBAS ĪPAŠNIEKA NOSAUKUMS sanofi-aventis groupe DERĪGUMA TERMIŅŠ
English: CoAprovel 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Latvian: CoAprovel 300 mg/12,5 mg tabletes ir iepakotas blisteru plāksnītēs pa 14, 28, 56 vai 98 tabletēm.
English: Based on available data from epidemiological studies, cumulative dosedependent association between HCTZ and NMSC has been observed.
Latvian: Nemelanomas ādas vēzis: pamatojoties uz pieejamajiem epidemioloģisko pētījumu datiem, novēroja no kumulatīvās devas atkarīgu saistību starp hidrohlortiazīdu un nemelanomas ādas vēzi.
English: EU/1/98/086/007 - 14 tablets EU/1/98/086/001 - 28 tablets EU/1/98/086/002 - 56 tablets EU/1/98/086/009 - 56 x 1 tablets EU/1/98/086/003 - 98 tablets
Latvian: EU/1/98/086/007 - 14 tabletes EU/1/98/086/001 - 28 tabletes EU/1/98/086/002 - 56 tabletes EU/1/98/086/009 - 56 x 1 tabletes EU/1/98/086/003 - 98 tabletes
English: Cartons of 14 tablets in PVC/PVDC/Aluminium blisters.
Latvian: Kastīte ar 14 tabletēm PVH/PVDH/alumīnija blisterī.
English: Each tablet of CoAprovel 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Latvian: Katra CoAprovel 150 mg/12,5 mg tablete satur 150 mg irbesartāna un 12,5 mg hidrohlortiazīda.
English: OTHER
Latvian: O
English: What CoAprovel looks like and contents of the pack CoAprovel 300 mg/25 mg film-coated tablets are pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Latvian: CoAprovel 300 mg/25 mg apvalkotās tabletes ir rozā, abpusēji izliektas, ovālas formas, ar sirdsveida iespiedumu vienā pusē un numuru 2788 otrā pusē.
English: CoAprovel 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Latvian: CoAprovel 300 mg/25 mg apvalkotās tabletes ir iepakotas blisteru plāksnītēs pa 14, 28, 30, 56, 84, 90 vai 98 apvalkotām tabletēm.
English: Sanofi Bulgaria EOOD Тел.
Latvian: Sanofi Malta Ltd.
English: Cartons of 98 tablets in PVC/PVDC/Aluminium blisters.
Latvian: Kastīte ar 98 tabletēm PVH/PVDH/alumīnija blisterī.
English: Cartons of 28 tablets in PVC/PVDC/Aluminium blisters.
Latvian: Kastīte ar 28 tabletēm PVH/PVDH/alumīnija blisterī.
English: CoAprovel 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Latvian: CoAprovel 150 mg/12,5 mg apvalkotās tabletes ir iepakotas blisteru plāksnītēs pa 14, 28, 30, 56, 84, 90 vai 98 apvalkotām tabletēm.
English: swelling extremity
Latvian: pietūkušas ekstremitātes
English: CoAprovel 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Latvian: CoAprovel 300 mg/25 mg apvalkotās tabletes Irbesartanum/hydrochlorothiazidum
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Latvian: KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS Katra apvalkotā tablete satur 300 mg irbesartāna (irbesartanum) un 25 mg hidrohlortiazīda (hydrochlorothiazidum).
English: EU/1/98/086/023 - 14 tablets EU/1/98/086/024 - 28 tablets EU/1/98/086/031 - 30 tablets EU/1/98/086/025 - 56 tablets EU/1/98/086/028 - 56 x 1 tablets EU/1/98/086/026 - 84 tablets EU/1/98/086/034 - 90 tablets EU/1/98/086/027 - 98 tablets
Latvian: EU/1/98/086/023 - 14 tabletes EU/1/98/086/024 - 28 tabletes EU/1/98/086/031 - 30 tabletes EU/1/98/086/025 - 56 tabletes EU/1/98/086/028 - 56 x 1 tabletes EU/1/98/086/026 - 84 tabletes EU/1/98/086/034 - 90 tabletes EU/1/98/086/027 - 98 tabletes
English: Preparations containing lithium should not be taken with CoAprovel without close supervision by your doctor.
Latvian: Ja Jūs neatrodaties stingrā ārsta uzraudzībā, litiju saturošus preparātus nedrīkst lietot kopā ar CoAprovel.
English: EU/1/98/086/011 - 14 tablets EU/1/98/086/012 - 28 tablets EU/1/98/086/029 - 30 tablets EU/1/98/086/013 - 56 tablets EU/1/98/086/014 - 56 x 1 tablets EU/1/98/086/021 - 84 tablets EU/1/98/086/032 - 90 tablets EU/1/98/086/015 - 98 tablets
Latvian: EU/1/98/086/011 - 14 tabletes EU/1/98/086/012 - 28 tabletes EU/1/98/086/029 - 30 tabletes EU/1/98/086/013 - 56 tabletes EU/1/98/086/014 - 56 x 1 tabletes EU/1/98/086/021 - 84 tabletes EU/1/98/086/032 - 90 tabletes EU/1/98/086/015 - 98 tabletes
English: Each film-coated tablet of CoAprovel 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Latvian: Katra CoAprovel 150 mg/12,5 mg apvalkotā tablete satur 150 mg irbesartāna un 12,5 mg hidrohlortiazīda.
English: What CoAprovel looks like and contents of the pack CoAprovel 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
Latvian: CoAprovel 300 mg/12,5 mg tabletes ir dzeltensārtas, abpusēji izliektas, ovālas formas, ar sirdsveida iespiedumu vienā pusē un numuru 2776 otrā pusē.
English: EU/1/98/086/016 - 14 tablets EU/1/98/086/017 - 28 tablets EU/1/98/086/030 - 30 tablets EU/1/98/086/018 - 56 tablets EU/1/98/086/019 - 56 x 1 tablets EU/1/98/086/022 - 84 tablets EU/1/98/086/033 - 90 tablets EU/1/98/086/020 - 98 tablets
Latvian: EU/1/98/086/016 - 14 tabletes EU/1/98/086/017 - 28 tabletes EU/1/98/086/030 - 30 tabletes EU/1/98/086/018 - 56 tabletes EU/1/98/086/019 - 56 x 1 tabletes EU/1/98/086/022 - 84 tabletes EU/1/98/086/033 - 90 tabletes EU/1/98/086/020 - 98 tabletes
English: Each tablet of CoAprovel 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Latvian: Katra CoAprovel 300 mg/12,5 mg tablete satur 300 mg irbesartāna un 12,5 mg hidrohlortiazīda.
English: Metabolism and nutrition disorders:
Latvian: Vielmaiņas un uztures traucējumi:
English: Peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
Latvian: Dzeltensārta, abpusēji izliekta, ovālas formas tablete ar sirdsveida iespiedumu vienā pusē un numuru 2776 otrā pusē.
English: Each film-coated tablet of CoAprovel 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Latvian: Katra CoAprovel 300 mg/12,5 mg apvalkotā tablete satur 300 mg irbesartāna un 12,5 mg hidrohlortiazīda.
English: CoAprovel 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Latvian: CoAprovel 300 mg/12,5 mg tabletes Irbesartanum/hydrochlorothiazidum
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Latvian: KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS Katra tablete satur 150 mg irbesartāna (irbesartanum) un 12,5 mg hidrohlortiazīda (hydrochlorothiazidum).
English: What CoAprovel looks like and contents of the pack CoAprovel 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Latvian: CoAprovel 150 mg/12,5 mg tabletes ir dzeltensārtas, abpusēji izliektas, ovālas formas, ar sirdsveida iespiedumu vienā pusē un numuru 2775 otrā pusē.
English: CoAprovel 300 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Latvian: CoAprovel 300 mg/12,5 mg apvalkotās tabletes ir iepakotas blisteru plāksnītēs pa 14, 28, 30, 56, 84, 90 vai 98 apvalkotām tabletēm.
English: What CoAprovel looks like and contents of the pack CoAprovel 300 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2876 engraved on the other side.
Latvian: CoAprovel 300 mg/12,5 mg apvalkotās tabletes ir dzeltensārts, abpusēji izliektas, ovālas formas, ar sirdsveida iespiedumu vienā pusē un numuru 2876 otrā pusē.
English: Peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2876 engraved on the other side.
Latvian: Dzeltensārta, abpusēji izliekta, ovālas formas tablete ar sirdsveida iespiedumu vienā pusē un numuru 2876 otrā pusē.
English: CoAprovel 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Latvian: CoAprovel 150 mg/12,5 mg tabletes Irbesartanum/hydrochlorothiazidum
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Latvian: KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS Katra tablete satur 300 mg irbesartāna (irbesartanum) un 12,5 mg hidrohlortiazīda (hydrochlorothiazidum).
English: Package leaflet: Information for the patient CoAprovel 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Latvian: Lietošanas instrukcija: informācija lietotājam CoAprovel 300 mg/25 mg apvalkotās tabletes irbesartanum/hydrochlorothiazidum
English: diarrhoea
Latvian: trombocitopēnija
English: What CoAprovel looks like and contents of the pack CoAprovel 150 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side.
Latvian: CoAprovel 150 mg/12,5 mg apvalkotās tabletes ir dzeltensārts, abpusēji izliektas, ovālas formas, ar sirdsveida iespiedumu vienā pusē un numuru 2875 otrā pusē.
English: Package leaflet: Information for the patient CoAprovel 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Latvian: Lietošanas instrukcija: informācija lietotājam CoAprovel 300 mg/12,5 mg tabletes irbesartanum/hydrochlorothiazidum
English: Package leaflet: Information for the patient CoAprovel 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Latvian: Lietošanas instrukcija: informācija lietotājam CoAprovel 150 mg/12,5 mg tabletes irbesartanum/hydrochlorothiazidum
English: Microcrystalline cellulose Croscarmellose sodium Lactose monohydrate Magnesium stearate Colloidal hydrated silica Pregelatinised maize starch Red and yellow ferric oxides (E172)
Latvian: Koloidāls hidratēts silīcija dioksīds Preželatinizēta kukurūzas ciete Dzelzs oksīdi, sarkanais un dzeltenais (E172)
English: Peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side.
Latvian: Dzeltensārta, abpusēji izliekta, ovālas formas tablete ar sirdsveida iespiedumu vienā pusē un numuru 2875 otrā pusē.
English: Talk to your doctor before taking CoAprovel and if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems or have a kidney transplant if you suffer from heart problems if you suffer from liver problems o if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
Latvian: Pirms CoAprovel lietošanas konsultējieties ar ārstu un ja kaut kas no zemāk minētā attiecas uz Jums: ja Jums parādās stipra vemšana vai caureja; ja Jums ir nieru slimība vai ir pārstādīta niere; ja Jums ir sirds slimība; ja Jums ir aknu slimība; ja Jums ir cukura diabēts;
English: Peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Latvian: Dzeltensārta, abpusēji izliekta, ovālas formas tablete ar sirdsveida iespiedumu vienā pusē un numuru 2775 otrā pusē.
English: fatigue
Latvian: nespēks
English: Periodic Safety Update Reports
Latvian: CITI REĢISTRĀCIJAS NOSACĪJUMI UN PRASĪBAS • Periodiski atjaunojamais drošuma ziņojums
English: Co-administration of thiazide diuretics may increase the incidence of hypersensitivity reactions to allopurinol;
Latvian: Vienlaikus lietošana ar tiazīdu grupas diurētikām var palielināt paaugstinātas jutības reakcijas biežumu pret alopurinolu.
English: NAME OF THE MEDICINAL PRODUCT CoAprovel 300 mg/12.5 mg film-coated tablets.
Latvian: ZĀĻU NOSAUKUMS CoAprovel 300 mg/12,5 mg apvalkotās tabletes.
English: Cartons of 30 film-coated tablets in PVC/PVDC/Aluminium blisters.
Latvian: Kastīte ar 30 tabletēm PVH/PVDH/alumīnija blisterī.
English: Each film-coated tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Latvian: Katra tablete satur 150 mg irbesartāna un 12,5 mg hidrohlortiazīda
English: Thiazide diuretic-associated azotaemia may occur in patients with impaired renal function.
Latvian: Pacientiem ar pavājinātu nieru darbību var rasties tiazīdu grupas diurētiku izraisīta azotēmija.
English: Cartons of 90 film-coated tablets in PVC/PVDC/Aluminium blisters.
Latvian: Kastīte ar 90 tabletēm PVH/PVDH/alumīnija blisterī.
English: No dosage adjustment of CoAprovel is necessary in older people.
Latvian: Gados vecākiem pacientiem CoAprovel deva nav jāpielāgo.
English: NDEA Limit in ppm in API
Latvian: Pieļaujamais daudzums (ppm) aktīvajā farmaceitiskajā vielā
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Latvian: KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS Katra apvalkotā tablete satur 300 mg irbesartāna (irbesartanum) un 12,5 mg hidrohlortiazīda (hydrochlorothiazidum).